Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02367300 · ClinicalTrials.gov registry record
Validation Of TBI Detection System For Head Injured Patients
A clinical trial of Brain Injuries, sponsored by BrainScope Company.
- Completed
- Registry status
- 981
- Enrollment target
- 11
- Study locations
NCT02367300: Completed study of Brain Injuries, sponsored by BrainScope Company.
NCT02367300 is a study of Brain Injuries that has completed, run by BrainScope Company. The registered enrollment target is 981 participants, above the 286-participant average among 22 other Brain Injuries trials with a reported enrollment target (243% higher). The trial reports 11 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02367300, a study of Brain Injuries, has completed, sponsored by BrainScope Company.
- COMPLETED
- Registry status
- 981 participants
- Enrollment target
- 11
- Study locations
Study Summary
A prospective, non-randomized trial to validate the database of brain electrical activity recordings and clinical information collected from patients who present to the ED following closed head injury.
Primary Outcome
The co-primary endpoints for this study are the sensitivity/specificity pair for CT+ identified by the Ahead 300 algorithm classification.
Conditions Studied
Interventions
- DEVICE BrainScope Ahead 200
Study Locations (11)
Michigan
- Wayne State University - Detroit Receiving Hospital - Detroit
- Wayne State University - Sinai Grace Hospital - Detroit
Texas
- Baylor University Medical Center - Dallas
- UT-Houston Health Science Center - Houston
Connecticut
- Hartford Hospital - Hartford
Georgia
- Emory University- Grady Hospital - Atlanta
Maryland
- R Cowley Shock Trauma Hospital - Baltimore
Missouri
- Washington University - Barnes Jewish Hospital - St Louis
New York
- University of Rochester Medical Center - Rochester
Pennsylvania
- Allegheny General Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 981 participants |
| Start Date | 2015-02 |
| Est. Completion | 2016-01 |
What the finished NCT02367300 record still lists
NCT02367300 is an observational study that tracks outcomes without assigning an intervention. The registered 981 participants enrollment target is mid-sized for trials with a published cap, above the 286-participant average among 22 other Brain Injuries trials with a reported enrollment target (243% higher).
The record links to 1 condition, with Brain Injuries appearing as the primary indexed condition, and to 1 intervention - of which BrainScope Ahead 200 is the first listed.
NCT02367300 lists 11 locations in 9 states (Michigan, Texas, Connecticut).
Frequently Asked Questions
What is clinical trial NCT02367300 about?
NCT02367300 is a clinical study titled "Validation Of TBI Detection System For Head Injured Patients". A prospective, non-randomized trial to validate the database of brain electrical activity recordings and clinical information collected from patients who present to the ED following closed head injury.
What is the current status of trial NCT02367300?
This trial is currently completed. The enrollment target is 981 participants. The study started on 2015-02. Estimated completion is 2016-01.
What conditions does trial NCT02367300 study?
This clinical trial studies the following conditions: Brain Injuries.
What interventions are being tested in trial NCT02367300?
The interventions under investigation include: BrainScope Ahead 200 (DEVICE).
Who is sponsoring clinical trial NCT02367300?
This trial is sponsored by BrainScope Company, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02367300 being conducted?
This trial has 11 study locations across Connecticut, Georgia, Maryland, Michigan, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02367300's enrollment target sits among peer trials
981 3rd of 22 higher than 20 of 22 other Brain Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
RECRUITING · NA
-
The Gut-Brain Axis During Neurorehabilitation; Prebiotic Treatment to Alter the Gut Microbiome and Neurologic Symptoms
RECRUITING · NA
-
Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma
RECRUITING · NA
-
Screening Emotions in Adolescents at the Hospital for mTBI
RECRUITING
-
Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions
RECRUITING · NA
-
The HOME Study (Healthy Options Made Easy): Telehealth Nutrition Sessions for People Living With Brain Injury
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06959095 · 981 participants · Phase 3
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
- NCT06989437 · 982 participants · Phase 2
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- NCT06337097 · 980 participants · NA
STRICT - Surveillance With TRoponin During Immune Checkpoint Therapy
- NCT07070232 · 980 participants · Phase 1
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia